Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRIDEX CORPIRIX · Entity 7882 | Director | June 14, 2023 | June 15, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRIDEX CORP
Report date June 14, 2023 · Filed June 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 160,103 |
Reported balance
After 2023-06-14 transaction · row 1
1 source rowRow 1 · 2023-06-14 · Grant · Acquired 39,267 · Balance 160,103 F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 14, 2024 or the date of the Issuer's next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 14, 2024 or the date of the Issuer's next annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2023 Filed Jun 15, 2023 22:57 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 39,267 | $1.91 | $74,999.97 |
DisclosureSEC source: 0001209191-23-037565 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,103 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 14, 2024 or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:43 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 27,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-037550 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,836 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 15, 2023 or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| December 02, 2021 Filed Dec 2, 2021 22:24 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 1,644 | $6.08 | $9,998.81 |
DisclosureSEC source: 0001209191-21-067672 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,364 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.055 to $6.0958, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 23:27 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 5,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-042265 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,720 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 16, 2022 or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 21:35 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 18,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-039136 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,300 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 24, 2021 or the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a member of the Issuer's Board of Directors through such date. Read SEC document |
| May 15, 2020 Filed May 18, 2020 22:32 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 15,125 | $1.68 | $25,446.30 |
DisclosureSEC source: 0001209191-20-030216 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,952 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.63 to $1.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 21:18 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 1,000 | $2.03 | $2,028.20 |
DisclosureSEC source: 0001209191-19-057155 · doc4.xml · nonDerivative · entry 3 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,827 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.025 to $2.0285, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 21:18 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 10,000 | $2.04 | $20,377.00 |
DisclosureSEC source: 0001209191-19-057155 · doc4.xml · nonDerivative · entry 2 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,827 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.03 to $2.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 21:18 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 3,600 | $2.04 | $7,344.00 |
DisclosureSEC source: 0001209191-19-057155 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,827 Read SEC document |
| November 15, 2019 Filed Nov 16, 2019 00:48 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 10,000 | $2.02 | $20,187.00 |
DisclosureSEC source: 0001209191-19-056833 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,227 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.005 to $2.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 23:05 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 5,303 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046713 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,227 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 23:10 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantCommon Stock | 11,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-043282 · doc4.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,924 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 01:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 863 | $4.30 | $3,710.90 |
DisclosureSEC source: 0001704739-18-000059 · edgar.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,720 Read SEC document |
| December 12, 2018 Filed Dec 12, 2018 23:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 3,684 | $4.32 | $15,903.46 |
DisclosureSEC source: 0001704739-18-000052 · edgar.xml · nonDerivative · entry 3 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,857 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 11, 2018 Filed Dec 12, 2018 23:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 4,673 | $4.18 | $19,542.49 |
DisclosureSEC source: 0001704739-18-000052 · edgar.xml · nonDerivative · entry 2 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,173 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.14 to $4.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 23:59 UTC | IRIDEX CORP IRIX · Entity 7882 | PurchaseCommon Stock | 2,500 | $4.17 | $10,432.00 |
DisclosureSEC source: 0001704739-18-000052 · edgar.xml · nonDerivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.16 to $4.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| October 15, 2018 Filed Oct 16, 2018 22:04 UTC | IRIDEX CORP IRIX · Entity 7882 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001704739-18-000048 · edgar.xml · derivative · entry 1 Grove Robert Earle · CIK 0001755510 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2025-10-15 F1 · security: This option was granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule 16b-3. F2 · derivative.exercise_date: The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest on November 15, 2018 and each month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.